secwatch.observer — SEC 8-K summary
======================================

Issuer:     WINDTREE THERAPEUTICS INC /DE/ (WINT)
CIK:        0000946486
Form:       8-K
Filed at:   2024-08-14T23:59:59+00:00
Accession:  0001437749-24-026816
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Windtree Therapeutics board reshuffled: two directors exit, two appointed, lead independent director named
--------------------------------------------------------------------------------

- Daniel Geffken and Leslie J. Williams resigned from the Board August 13, 2024; no disagreement with company.
- Board appointed Jed Latkin and Saundra Pelletier as directors; Latkin chairs Audit, Pelletier chairs Compensation.
- Mark Strobeck, Ph.D., appointed lead independent director effective August 13, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946486/000143774924026816/0001437749-24-026816-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946486/000143774924026816/wint20240812_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-026816

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer